Cholesterol and the risk of renal dysfunction in apparently healthy men
Abstract
Despite extensive knowledge about abnormal lipid patterns in patients with end-stage renal disease, the association between cholesterol and the development of renal dysfunction is unclear. We evaluated this association in a prospective cohort study among 4,483 initially healthy men participating in the Physicians' Health Study who provided blood samples in 1982 and 1996. Main outcome measures were elevated creatinine, defined as >/= 1.5 mg/dl (133 micromol/L), and reduced estimated creatinine clearance, defined as /= 240 mg/dl), HDL ( /= 40 mg/dl), total non-HDL cholesterol, and the ratio of total cholesterol to HDL. We used logistic regression to calculate age- and multivariable adjusted odds ratios as a measure for the relative risk. After 14 yr, 134 men (3.0%) had elevated creatinine and 244 (5.4%) had reduced creatinine clearance. The multivariable relative risk for elevated creatinine was 1.77 (95% confidence interval [CI], 1.10 to 2.86) for total cholesterol >/= 240 mg/dl, 2.16 (95% CI, 1.42 to 3.27) for HDL /= >6.8), and 2.16 (95% CI, 1.22 to 3.80) for the highest quartile of non-HDL cholesterol (>/= 196.1). Similar although smaller associations were observed between cholesterol parameters and reduced creatinine clearance. Elevated total cholesterol, high non-HDL cholesterol, a high ratio of total cholesterol/HDL, and low HDL in particular were significantly associated with an increased risk of developing renal dysfunction in men with an initial creatinine <1.5 mg/dl.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Dyslipidemia is a risk factor for progressive kidney disease.
“While dyslipidemia is a risk factor for progressive kidney disease (8,10,20,21)”
From Effects of Fibrates in Kidney Disease (2012) · cites this paper as [20]
Cites
COLDITZ, G. A., MARTIN, P., STAMPFER, M. J., WILLETT, W. C., SAMPSON, L., ROSNER, B., HENNEKENS, C. H., & SPEIZER, F. E. (1986) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114319 · Cited by 992 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Effects of Fibrates in Kidney Disease
Jun, M., Zhu, B., Tonelli, M., Jardine, M. J., Patel, A., Neal, B., Liyanage, T., Keech, A., Cass, A., & Perkovic, V. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.049 · Cited by 189 · see citing works
Lin, Y.-C., Lai, T.-S., Chen, Y.-T., Chou, Y.-H., Chen, Y.-M., Hung, K.-Y., & Tu, Y.-K. (2025) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2024.09.037 · Cited by 8 · see citing works
- Authors
- Schaeffner, E. S., Kurth, T., Curhan, G. C., Glynn, R. J., Rexrode, K. M., Baigent, C., Buring, J. E., & Gaziano, J. M.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Kurth, Tobias
- Glynn, Robert J.
- Rexrode, Kathryn M.
- Buring, Julie E.
- Gaziano, J. Michael
- ORCID
- Venue
- Journal of the American Society of Nephrology
- Published
- 2003-08
- Volume
- 14
- Issue
- 8
- Pages
- 2084-2091
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2120479558
- Cited by
- 442
- References
- 1
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 18 · 2023: 19 · 2022: 24 · 2021: 21 · 2020: 23 · 2019: 13 · 2018: 19 · 2017: 23 · 2016: 23 · 2015: 20 · 2014: 24 · 2013: 18 · 2012: 22
- FWCI
- 11.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01CA097193)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- cholesterol, renal dysfunction, HDL cholesterol, non-HDL cholesterol, TC/HDL-C ratio, creatinine elevation, end-stage renal disease, lipid metabolism, men, Physicians' Health Study
- MeSH terms
- Cholesterol, Creatinine, Edetic Acid, Glomerular Filtration Rate, Humans, Kidney Diseases, Kidney Failure, Chronic, Cholesterol, HDL, Male, Prospective Studies, Risk, Time Factors, Cohort Studies, Multivariate Analysis, Logistic Models, Odds Ratio, Treatment Outcome, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review